cytoreductive therapy
Showing 1 - 25 of >10,000
Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Not yet recruiting
- Metastatic Prostate Cancer
- Castration-Sensitive Prostate Cancer
- apalutamide
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Feb 4, 2023
Colorectal Tumors, Colorectal Cancer, Colorectal Cancer Metastatic Trial in Guangzhou (Preoperative systematic therapy,
Not yet recruiting
- Colorectal Neoplasms
- +8 more
- Preoperative systematic therapy
- +2 more
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital of Sun Yat-sen University
Apr 28, 2022
Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- Azacitidine
- +2 more
-
Scottsdale, Arizona
- +3 more
Jan 12, 2023
Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)
Recruiting
- Stage IV Prostate Adenocarcinoma AJCC v7
- Antiandrogen Therapy
- +5 more
-
Duarte, California
- +15 more
Jan 24, 2023
LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)
Suspended
- LMS - Leiomyosarcoma
- Uterine Leiomyosarcoma
- Gemcitabine
- +5 more
-
Stanford, CaliforniaStanford University
Oct 24, 2022
Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)
Not yet recruiting
- Metastatic Cancer
- +7 more
- Standard of Care Chemotherapy
- +7 more
- (no location specified)
Apr 1, 2022
Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))
Suspended
- Gastroenteropancreatic Neuroendocrine Tumor
- Lutathera
- +4 more
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Sep 21, 2022
Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Pancreas Cancer
- cytoreductive surgery
- +2 more
-
Chicago, IllinoisThe University of Chicago
Nov 8, 2022
Ovarian Cancer, Intraperitoneal Chemo Trial in Montpellier (Intraperitoneal chemo during surgery)
Recruiting
- Ovarian Cancer
- Intraperitoneal Chemotherapy
- Intraperitoneal chemotherapy during surgery
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022
Colorectal Tumor, Colorectal Cancer, Colorectal Tumors Malignant Trial in Belgium, Netherlands (other, combination product,
Recruiting
- Colorectal Neoplasm
- +10 more
- Perioperative systemic therapy
- +5 more
-
Genk, Vlaanderen, Belgium
- +8 more
Jul 28, 2021
Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the Bone Trial in Duarte,
Completed
- Metastatic Prostate Carcinoma
- +2 more
- Robotic Assisted Radical Prostatectomy
- +4 more
-
Duarte, California
- +2 more
Apr 7, 2021
HIV Trial in Chapel Hill, Durham (Nelfinavir mesylate, Lamivudine, Filgrastim)
Completed
- HIV Infections
- Nelfinavir mesylate
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2021
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)
Terminated
- Neuroendocrine Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020
Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)
Not yet recruiting
- Renal Cell Carcinoma
- Cytoreductive Nephrectomy
- (no location specified)
Jul 3, 2023
Ovarian Cancer Trial in Goyang (Cisplatin)
Not yet recruiting
- Ovarian Cancer
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center
Apr 24, 2023
Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)
Not yet recruiting
- Ovarian Cancer
- Drug Related Neoplasm/Cancer
- secondary cytoreductive surgery
- chemotherapy
- (no location specified)
Jan 28, 2023
Prostate Cancer, Metastatic Prostate Cancer Trial in United Kingdom (Standard of Care, Minimally Invasive Ablative Therapy
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Standard of Care
- +2 more
-
Birkenhead, United Kingdom
- +13 more
Feb 11, 2021
Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive
Recruiting
- Kidney Cancer
- +2 more
- Cytoreductive nephrectomy±metastasectomy
- Human-derived materials sampling
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 2, 2023
Colorectal Tumors Trial in Gent (perioperative chemo plus bevacizumab, cytoreductive surgery, Intraperitoneal Oxaliplatin)
Active, not recruiting
- Colorectal Neoplasms
- perioperative chemotherapy plus bevacizumab
- +2 more
-
Gent, BelgiumGhent University Hospital
Dec 12, 2022
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Milano, Milan (APA + ADT, Local Treatmetn RT or RP)
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- APA + ADT
- Local Treatmetn RT or RP
-
Milano, Lombardia, Italy
- +2 more
Jan 17, 2023
Metastatic Renal Cell Carcinoma Trial in Australia, Canada (Ipilimumab/ Nivolumab, SBRT + Ipilimumab/Nivolumab)
Recruiting
- Metastatic Renal Cell Carcinoma
- Ipilimumab/ Nivolumab
- SBRT + Ipilimumab/Nivolumab
-
Melbourne, Australia
- +7 more
Mar 30, 2022
Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)
Recruiting
- Acute Promyelocytic Leukemia
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Apr 26, 2023
Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National
Not yet recruiting
- Malignant Pleural Mesotheliomas (Mpm)
- +4 more
- Cytoreductive surgery
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Ovarian Cancer Trial in Shanghai (Etoposide, Cyclophosphamide, Carboplatin)
Active, not recruiting
- Ovarian Cancer
- Etoposide, Cyclophosphamide, Carboplatin
-
Shanghai, Shanghai, ChinaWu Xiaohua
Jul 25, 2022
Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],
Recruiting
- Myeloproliferative Neoplasm
- +5 more
- Apixaban 2.5 MG Oral Tablet [ELIQUIS]
- Aspirin 81 mg
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Apr 19, 2022